![Person tacking medicine from a shelf](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-06_GLP1%20recommendations-3-_WEB_homepage-banner.png?itok=A_0z_r-H)
New recommendations to ensure these medicines reach those who need them most
![Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-06_CTIS%20transparency%20rules_WEB_homepage-banner.png?itok=FOCrNJBT)
Revised transparency rules for Clinical Trials Information System (CTIS) have become applicable
![Image showing pills and a magnifying glass](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/D10_WEB_PRAC%20highlights_homepage_slider_0.png?itok=UJI2iLE6)
Start of review of painkiller metamizole and risk of secondary cancers with CAR T-cell medicines
![Image showing a meeting room filled with people](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024_ManagementBoard-2-_WEB-slider_v1.png?itok=bcRXT9pz)
Board adopts Executive Director’s 2023 annual activity report and is updated on new fee regulation
![A doctor and a patient looking at a screen](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-06/2024-6_ACT%20EU%20pilots_WEB_homepage-banner.png?itok=-sOPJjH_)
EU collaboration to foster high-quality clinical research
![Image of annual report cover showing on laptop, leaflet, ipad, phone](https://www.ema.europa.eu/sites/default/files/styles/ema_carousel/public/2024-05/2024-05_Annual-report-2023-2-_WEB_slider.png?itok=7d5CVHjq)
How we contributed to public and animal health in the European Union
Find medicine
What's new
FAQs
Latest news
![Pharmacist opening medicine drawer](https://www.ema.europa.eu/sites/default/files/2024-06/2024-06_GLP1%20recommendations-2-_WEB_square.png)
MSSG recommendations for all stakeholders and upcoming multistakeholder workshop
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
![Faster access to clinical trial information in Europe](https://www.ema.europa.eu/sites/default/files/2024-06/2024-06_CTIS%20transparency%20rules_WEB_square.png)
Revised rules for Clinical Trials Information System (CTIS) become applicable
Review will look into risk of agranulocytosis, a sudden drop in white blood cells that can lead to serious infections, and measures to minimise it.
Start of review of painkiller metamizole and risk of secondary cancers with CAR T-cell medicines.
![Management Board June 2024](https://www.ema.europa.eu/sites/default/files/2024-06/2024_ManagementBoard-3-_WEB-square_v1.png)
Board adopts Executive Director’s annual activity report for 2023 and hears updates on implementation of new fee regulation.
Events
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
The Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) was established under Regulation 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices.
EMA is holding its ninth quarterly meeting of the Industry Standing Group (ISG).